2-{2-[4-(5-thioxo-5H-1,2,3-dithiazol-4-yl)piperazin-1-yl]ethyl}isoindoline-1,3-dione

ID: ALA4864075

Chembl Id: CHEMBL4864075

PubChem CID: 164622653

Max Phase: Preclinical

Molecular Formula: C16H16N4O2S3

Molecular Weight: 392.53

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2ccccc2C(=O)N1CCN1CCN(c2nssc2=S)CC1

Standard InChI:  InChI=1S/C16H16N4O2S3/c21-14-11-3-1-2-4-12(11)15(22)20(14)10-7-18-5-8-19(9-6-18)13-16(23)24-25-17-13/h1-4H,5-10H2

Standard InChI Key:  KTMKDWHFFOKEQF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4864075

    ---

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
5637 (630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.53Molecular Weight (Monoisotopic): 392.0435AlogP: 2.35#Rotatable Bonds: 4
Polar Surface Area: 56.75Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.94CX LogP: 2.42CX LogD: 2.41
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -1.43

References

1. Maffuid KA, Koyioni M, Torrice CD, Murphy WA, Mewada HK, Koutentis PA, Crona DJ, Asquith CRM..  (2021)  Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agents.,  43  [PMID:33951490] [10.1016/j.bmcl.2021.128078]

Source